President of Q BioMed Inc. Expands on Corporate Update in Q&A

Denis Corin Discusses Mannin Research Inc’s Leading Glaucoma Drug Candidate MAN-01   POINT ROBERTS, WA–(Marketwired – March 21, 2016) –  Investorideas.com, a digital global news source covering leading sectors including medical technology and biotech stocks releases a recent interview with Mr. Denis Corin, President of Q BioMed Inc. (OTCQB: QBIO). Denis expands on the recent corporate […]

Read More

Q BIOMED INC. CONGRATULATES MANNIN RESEARCH ON SELECTION TO THE CHICAGO-CANADA MENTORSHIP PROGRAM (C2MP) AND INAUGURAL MEETING

Mannin assigned world class industry mentors and advisors NEW YORK, March 17, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to congratulate Mannin Research on its selection to the C2MP program and the exceptional mentors and advisors now included in the long list of industry experts available to assist in […]

Read More

Q BioMed Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

New York, NY– (February 16, 2016)– Q BioMed Inc. (OTCQB: QBIO) a biotechnology acceleration company, today announced that the company will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at The Ritz-Carlton in Miami on South Beach on February 22, 2016.  Please click here for a list of presenting companies. […]

Read More

Q BIOMED INC. PROVIDES A CORPORATE UPDATE

Company Closes $1,000,000 in Notes and Securities Purchase Agreements     NEW YORK, February 4, 2016 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to provide the following update on recent corporate developments. Over the last 3 months we have significantly increased our cash position through several convertible note and securities […]

Read More

Q BIOMED INC. TO PRESENT AT BIOTECH SHOWCASE(™) 2016

NEW YORK, January 5, 2106 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company announced today that Denis Corin, Chief Executive Officer, will present at the Biotech Showcase(™) 2016 Conference to be held January 11 through January 13, 2016 in San Francisco, California.   Details of QBioMed’s’ participation are as follows: Event:   Biotech […]

Read More

Q BIOMED INC. APPOINTS INDUSTRY EXECUTIVE TO MANAGEMENT TEAM

Company welcomes David Laskow-Pooley, former GSK, Abbott, Amersham executive to its management team   NEW YORK, December 16, 2015 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to welcome David Laskow-Pooley to the Q Team as VP Scientific & Product Development. Mr. Laskow-Pooley has 30 years of experience in all aspects […]

Read More

Q BIOMED INC. UPLISTED TO OTCQB MARKET

NEW YORK, November 13, 2015 — Q BioMed Inc. (OTCQB: QBIO), today announced that its common stock is being uplisted to the OTCQB effective November 13, 2015.   The OTCQB® Venture Marketplace is for entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an […]

Read More

Q BIOMED INC. STRENGTHENS ADVISORY BOARD

Company welcomes Dr. Susan E Quaggin, Dr. George Nikopoulos and Dr. MaryJane Rafii to its list of strategic advisors   NEW YORK, November 12, 2015 — Q BioMed Inc. (OTC Pink: QBIO), a biotechnology acceleration company is pleased to announce the addition of Mannin Research Inc. executives, Dr. Susan E Quaggin and Dr. George Nikopoulos […]

Read More

Vision Monday – Q BioMed Inc. and Mannin Research Inc. Sign Definitive License Agreement

Latest News Q BioMed Inc. and Mannin Research Inc. Sign Definitive License Agreement  By Staff Friday, November 6, 2015 12:18 AM NEW YORK—Q BioMed Inc. (OTC Pink: QBIO), a biotechnology acceleration company has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc., a biotechnology company leading the […]

Read More
Social media & sharing icons powered by UltimatelySocial